Skip to main content
Log in

Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Serum copper, zinc levels, and the Cu/Zn ratio were evaluated in 31 patients with breast cancer and 35 healthy controls. Copper and zinc were determined by atomic absorbtion spectrophotometry. The mean serum copper level and the mean Cu/Zn ratio in patients with breast cancer were significantly higher than the control group (p<0.001 andp<0.001). In addition, the mean serum zinc level in patients with breast cancer was significantly lower than the control group (p<0.001). Neither serum copper and zinc levels nor the Cu/Zn ratio were of value in discriminating of the disease activity and severity. Interestingly, the Cu/Zn ratio in premenopausal patients was higher than postmenopausal patients (p<0.05) and this was not related to age. The further combined biological and epidemiological studies are necessary to investigate the roles of copper and zinc in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. G. Westman and S. L. Marklung,Cancer Res. 41, 2962–2966 (1981).

    PubMed  CAS  Google Scholar 

  2. S. L. Rizk and H. H. Sky-Peck,Cancer Res. 44, 5390–5394 (1984).

    PubMed  CAS  Google Scholar 

  3. M. Abdulla, A. Biorklund, A. Mathur, et al.:J. Surg. Oncol. 12, 107–113 (1979).

    Article  PubMed  CAS  Google Scholar 

  4. Y. Aldor, N. Walach, D. Modai, et al:Klin. Woechenschr. 60, 375–377 (1982).

    Article  CAS  Google Scholar 

  5. H. T. Delves, F. W. Alexander, and H. Lay,Haematology 24, 525–531 (1973).

    Article  CAS  Google Scholar 

  6. G. L. Fisher, V. S. Byeres, M. Shitrine, et al:Cancer 37, 356–363 (1976).

    Article  PubMed  CAS  Google Scholar 

  7. S. Inutsuka and S. Araki,Cancer 42, 626–631 (1978).

    Article  PubMed  CAS  Google Scholar 

  8. M. K. Schwartz,Cancer Res. 29, 21–25 (1974).

    Google Scholar 

  9. S. Mortazaui, A. Bani-Hashemi, M. Mozaferi, et al:Cancer 29, 1193–1198 (1972).

    Article  Google Scholar 

  10. J. Wilimas, E. Thompson, and K. L. Smith,Cancer 42, 1929–1935 (1978).

    Article  PubMed  CAS  Google Scholar 

  11. D. N. Breiter, R. B. Diasio, J. P. Neifeld, et al:Cancer 42, 598–602 (1982).

    Article  Google Scholar 

  12. F. Cavallo, M. G. Gerber, E. Marubini, et al:Cancer 67, 738–745 (1990).

    Article  Google Scholar 

  13. J. Garofalo, H. Ashikari, M. L. Lesser, et al:Cancer 46, 2682–2585 (1980).

    Article  PubMed  CAS  Google Scholar 

  14. W. Holtkamp, J. Thiery, H. Rauschecker, et al:Onkologie 13, 207–209 (1990).

    Article  PubMed  CAS  Google Scholar 

  15. M. Percudani, B. Dell'Anna, F. F. De Lorenzis, et al:Int. Surg. 66, 233–236 (1981).

    PubMed  CAS  Google Scholar 

  16. G. Alfthan, and J. Kumpulainen,Analyt. Chim Acta 140, 221–227 (1982).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yücel, I., Arpaci, F., Özet, A. et al. Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol Trace Elem Res 40, 31–38 (1994). https://doi.org/10.1007/BF02916818

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02916818

Index Entries

Navigation